Canton Strategic Holdings (CNTN) Total Liabilities (2020 - 2026)
Canton Strategic Holdings posted quarterly Total Liabilities of $114.9 million for Q1 2026, up 4538.81% year-on-year from $2.5 million in Q1 2025, and down 5.25% on a QoQ basis from $121.2 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 7 years of Total Liabilities data on file, last reported at $114.9 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 4538.81% year-over-year to $114.9 million; the trailing twelve-month figure through Mar 2026 stood at $114.9 million (up 4538.81% YoY), and the FY2025 full-year result was $121.2 million, up 4921.6% from the prior year.
- Total Liabilities for Q1 2026 stood at $114.9 million, down from $121.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $121.2 million in Q4 2025 and bottomed at $902348.0 in Q3 2022.
- The 5-year median for Total Liabilities is $1.8 million (2022), against an average of $15.4 million.
- The widest annual swing landed in 2022, when Total Liabilities sank 87.37%; it then jumped 4921.6% in 2025.
- A 5-year view of Total Liabilities shows it stood at $1.1 million in 2022, then jumped by 58.52% to $1.8 million in 2023, then soared by 33.0% to $2.4 million in 2024, then surged by 4921.6% to $121.2 million in 2025, then slipped by 5.25% to $114.9 million in 2026.
- The last three Total Liabilities figures came in at $114.9 million (Q1 2026), $121.2 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 114.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.86 Mn |
| Dec 31, 2025 | 121.22 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Dec 31, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.84 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 902,348.00 |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 5.31 Mn |
| Sep 30, 2021 | 7.14 Mn |
| Jun 30, 2021 | 6.30 Mn |
| Mar 31, 2021 | 5.29 Mn |
| Dec 31, 2020 | 4.01 Mn |